[FILM-Users 00202] Fwd: Definiens Symposium 2012 in München
...forwarded, for your information; should be an interesting meeting, Martin -------- Original Message -------- Subject: Definiens Symposium 2012 in München Date: Fri, 4 May 2012 17:47:12 +0200 From: Zimmermann, Johannes <jzimmermann@definiens.com> To: <m.spitaler@imperial.ac.uk> CC: Huber, Monika <mhuber@definiens.com> Hello Martin, I regret very much not seeing you in Munich at the Symposium in June (14-16). Maybe the event (especially the workshops) would be interesting for people in your group as well. As discussed, please find below some additional information: Symposium Page: http://www.definiens.com/community/symposium.html Program: http://www.definiens.com/community/symposium/symposium-2012-program.html Workshops: http://www.definiens.com/community/symposium/symposium-2012-workshops.html Registration: http://info.definiens.com/2012Symposium_RegistrationPage.html Please let me know if you have further questions. Kind regards Johannes cid:image001.jpg@01CD02D1.DBAE0E10 ------------------------------------------------------------------------ *Dr. Johannes Zimmermann* Director Business Development Life Sciences Definiens AG Bernhard-Wicki-Str. 5 80636 München Germany Tel. +49 (89) 231180 32 Fax. +49 (89) 231180 90 Mob. +49 (162) 2665580 jzimmermann@definiens.com <mailto:jzimmermann@definiens.com> http://www.definiens.com <http://www.definiens.com/> cid:image002.png@01CD02D1.DBAE0E10 <http://www.definiens.com/community/symposium.html> ------------------------------------------------------------------------ *Deeper Insights - Faster Results - Better Decisions* ------------------------------------------------------------------------ Sitz der Gesellschaft/Registered Office: Munich, Germany; Vorstand/Executive Board: Thomas Heydler (Vorsitzender/CEO), Dr. Markus Rinecker; Vorsitzender des Aufsichtsrats/Chairman of the Supervisory Board: Friedrich Bornikoel Registergericht/Commercial Register München HRB 133088 This e-mail may contain trade secrets or privileged, undisclosed, or otherwise confidential information. If you have received this e-mail in error, you are hereby notified that any review, copying, or distribution of it is strictly prohibited. Please inform us immediately and destroy the original transmittal. Thank you for your cooperation. ------------------------------------------------------------------------ /IMPORTANT: The contents of this email and any attachments are confidential. They are intended for the named recipient(s) only. If you have received this email in error, please notify the system manager or the sender immediately and do not disclose the contents to anyone or make copies thereof. /**** eSafe scanned this email for viruses, vandals, and malicious content. **** ------------------------------------------------------------------------
participants (1)
-
Martin Spitaler